Inflarx N V Revenue per Employee (IFRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Inflarx N V  (NASDAQ: IFRX)
 

Inflarx N V's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Inflarx N V's Revenue per employee fell on a trailing twelve month basis to $ 1,193, below the company average number of $796.
Within the Healthcare sector Employees of 583 other companies have achieved higher revenue per employee. While Inflarx N V's total ranking has deteriorated compared to the previous quarter from to 3977. Inflarx N V has 65 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IFRX Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Revenue Change 379.99 % - - - -
Sales per Employee (TTM) $ 1,193 793 1,880 1,192 1,192
IFRX's Total Ranking # 3977 # # # #
Seq. Revenue Change - - - - -90.31 %

IFRX Company Profile >> Back to IFRX Efficiency Comparisons >> Compare IFRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 221
Healthcare Sector # 584
Overall Market # 3977

Revenue per Employee Statistics
High Average Low
$ 1,087 $ 796 $ 505
(Dec 31 2023)   (Dec 31 2025)



Financial Statements
Inflarx N V's Revenue MRQ $ 0 Millions Visit IFRX's Income Statement
Inflarx N V's Revenues TTM $ 0 Millions Visit IFRX's aggregate revenue growth
What are IFRX's Sales? Visit IFRX's Sales by Segment




Other Ratios
Inflarx N V's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IFRX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IFRX's Competitors
Revenue per Employee for IFRX's Suppliers
Revenue per Employee for IFRX's Customers

You may also want to know
IFRX's Sales Growth Rates IFRX's Pe Price to earnings ratio IFRX's Receivables Turnover Ratio IFRX's Stock Quote
IFRX's Net Income Growth Rates IFRX's Ps Price to Sales ratio IFRX's Sales per Employee IFRX's Asset Turnover Ratio
IFRX's Net Margin IFRX's Pb Price to Book ratio IFRX's Financial Strength Ratios IFRX's Dividend Payout Ratio
Date modified: 2026-07-07T11:32:40+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Addex Therapeutics Ltd  1,763.06 $ 0.030  Million 17 
Pavmed Inc   1,731.71 $ 0.071  Million 41 
Hcw Biologics Inc   1,546.14 $ 0.054  Million 35 
Sera Prognostics Inc   1,125.00 $ 0.081  Million 72 
Kazia Therapeutics Limited  893.62 $ 0.042  Million 47 
Cardio Diagnostics Holdings Inc   872.06 $ 0.015  Million 17 
Altimmune inc   719.30 $ 0.041  Million 57 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.